Inventor · disambiguated record
Christopher A. Rhodes
Also filed as: RHODES CHRISTOPHER · RHODES CHRISTOPHER A
9 granted patents·22 pending applications·1,096 citations·filing 1994–2025
91Inventor score
Files withPHARMACEUTICAL DISCOVERY CORP6AMYLIN PHARMACEUTICALS INC3AMYLIN PHARMACEUTICALS LLC3PRONEUROGEN INC3UNIV VANDERBILT3
Top patents by PatentIndex Score
31 records- 0196US6071497AMicroparticles for lung delivery comprising diketopiperazinePHARMACEUTICAL DISCOVERY CORP·Filed 1997·Granted Jun 6, 2000·365 cites·14 claims
- 0296US5503852AMethod for making self-assembling diketopiperazine drug delivery systemPHARMACEUTICAL DISCOVERY CORP·Filed 1994·Granted Apr 2, 1996·403 cites·28 claims
- 0395US6428771B1Method for drug delivery to the pulmonary systemPHARMACEUTICAL DISCOVERY CORP·Filed 1995·Granted Aug 6, 2002·215 cites·12 claims
- 0493US8394414B2Method for drug delivery to the pulmonary systemSTEINER SOLOMON S·Filed 2003·Granted Mar 12, 2013·47 cites·11 claims
- 0582US5576436AFluorescent ligandsPHARMACEUTICAL DISCOVERY CORP·Filed 1994·Granted Nov 19, 1996·59 cites·10 claims
- 0674US2025332213A1Extended-release injectable gel formulations containing angiotensin-(1-7) oligopeptides or variants thereofPRONEUROGEN INC·Filed 2025·Application pending·0 cites
- 0774US2025281566A1Extended-release injectable gel formulations containing angiotensin-(1-7) oligopeptides or variants thereofPRONEUROGEN INC·Filed 2025·Application pending·0 cites
- 0872US2025057923A1Systems, compositions and methods for treating diabetesUNIV VANDERBILT·Filed 2024·Application pending·0 cites
- 0971US2022331395A1Extended-release injectable gel formulations containing angiotensin-(1-7) oligopeptides or variants thereofPRONEUROGEN INC·Filed 2022·Application pending·0 cites
- 1069US2009291886A1Transmucosal delivery of peptides and proteinsAMYLIN PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 1168US2015111824A1Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1265US2022273771A1Systems, compositions and methods for treating diabetesUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1364US2015265541A1Biodegradable Microcapsules Containing Filling MaterialAKINA INC·Filed 2013·Application pending·0 cites
- 1464US2020390715A1Biodegradable Microcapsules Containing Filling MaterialOHR PHARMA LLC·Filed 2020·Application pending·0 cites
- 1564US2008200383A1Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 1663US2015157725A1Transmucosal delivery of peptides and proteinsAMYLIN PHARMACEUTICALS LLC·Filed 2014·Application pending·0 cites
- 1763US2018185296A1Biodegradable Microcapsules Containing Filling MaterialOHR PHARMA LLC·Filed 2017·Application pending·0 cites
- 1862US2024033286A1Emollient topical disinfectantsI2PURE CORP·Filed 2023·Application pending·0 cites
- 1958US2003017211A1Method for drug delivery to the pulmonary systemPHARMACEUTICAL DISCOVERY CORP·Filed 2002·Application pending·0 cites
- 2058US2005215475A1Transmucosal delivery of peptides and proteinsONG JOHN·Filed 2005·Application pending·0 cites
- 2156US2009069226A1Transmucosal delivery of peptides and proteinsAMYLIN PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2254US11596648B2Emollient topical disinfectantsI2PURE CORP·Filed 2017·Granted Mar 7, 2023·0 cites·14 claims
- 2352US11357829B2Systems, compositions and methods for treating diabetesUNIV VANDERBILT·Filed 2018·Granted Jun 14, 2022·0 cites·23 claims
- 2451US2022354782A1Subcutaneously injectable insulin and glucagon formulations and methods of administrationCASS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 2549US2023293639A1Systems, devices, compositions, and methods for treating diabetesABVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2648US2016120950A1Pharmaceutical Formulations Comprising Incretin Mimetic Peptide and Aprotic Polar SolventAMYLIN PHARMACEUTICALS LLC·Filed 2015·Application pending·0 cites
- 2746US2023330040A1Immunological effects of metabolitesUNIV CALIFORNIA·Filed 2021·Application pending·0 cites
- 2842US12128201B2Capsule device for delivery of active agent to gastrointestinal tractBAYWIND BIOVENTURES·Filed 2019·Granted Oct 29, 2024·0 cites·33 claims
- 2941US5712269AM2 receptor ligand for the treatment of neurological disordersPHARMACEUTICAL DISCOVERY CORP·Filed 1995·Granted Jan 27, 1998·7 cites·10 claims
- 3039US2005042280A1Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofolFiled 2002·Application pending·0 cites
- 3139US2020282008A1COMPOSITIONS AND METHODS FOR LONG TERM RELEASE OF GONADOTROPIN-RELEASING HORMONE (GnRH) ANTAGONISTSVERU INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher A. Rhodes files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →